ARTICLE | Clinical News
Unigene regulatory update
September 14, 1998 7:00 AM UTC
UGNE received U.S. Patent No. 5,789,234 claiming the gene for the company's amidating enzyme and use of the gene for the production of pharmaceutical peptides. UGNE uses the technology in its manufact...